CA2460440A1 - Sels d'acide salicylique, procedes de production et d'utilisation desdits sels en tant que medicaments - Google Patents

Sels d'acide salicylique, procedes de production et d'utilisation desdits sels en tant que medicaments Download PDF

Info

Publication number
CA2460440A1
CA2460440A1 CA002460440A CA2460440A CA2460440A1 CA 2460440 A1 CA2460440 A1 CA 2460440A1 CA 002460440 A CA002460440 A CA 002460440A CA 2460440 A CA2460440 A CA 2460440A CA 2460440 A1 CA2460440 A1 CA 2460440A1
Authority
CA
Canada
Prior art keywords
methyl
enantiomers
optionally
formula
groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002460440A
Other languages
English (en)
Inventor
Gunter Linz
Rainer Soyka
Andre Steiner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2001145438 external-priority patent/DE10145438A1/de
Priority claimed from DE2002116125 external-priority patent/DE10216125A1/de
Application filed by Individual filed Critical Individual
Publication of CA2460440A1 publication Critical patent/CA2460440A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/08—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom
    • C07C217/10—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La présente invention concerne de nouveaux sels d'acide salicylique du salmétérol substitués ainsi que des procédés de production et d'utilisation desdits sels en tant que médicaments.
CA002460440A 2001-09-14 2002-09-06 Sels d'acide salicylique, procedes de production et d'utilisation desdits sels en tant que medicaments Abandoned CA2460440A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE2001145438 DE10145438A1 (de) 2001-09-14 2001-09-14 Neue Arzneimittel zur Inhalation
DE10145438.4 2001-09-14
DE10216125.9 2002-04-12
DE2002116125 DE10216125A1 (de) 2002-04-12 2002-04-12 Salicylsäuresalze, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
PCT/EP2002/009975 WO2003024440A1 (fr) 2001-09-14 2002-09-06 Sels d'acide salicylique, procedes de production et d'utilisation desdits sels en tant que medicaments

Publications (1)

Publication Number Publication Date
CA2460440A1 true CA2460440A1 (fr) 2003-03-27

Family

ID=26010150

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002460440A Abandoned CA2460440A1 (fr) 2001-09-14 2002-09-06 Sels d'acide salicylique, procedes de production et d'utilisation desdits sels en tant que medicaments

Country Status (7)

Country Link
EP (1) EP1429751A1 (fr)
JP (1) JP4199114B2 (fr)
CA (1) CA2460440A1 (fr)
MX (1) MXPA04002400A (fr)
PE (1) PE20030444A1 (fr)
UY (1) UY27443A1 (fr)
WO (1) WO2003024440A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013001457A1 (fr) * 2011-06-30 2013-01-03 Ranbaxy Laboratories Limited Nouveaux sels de sitagliptine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives

Also Published As

Publication number Publication date
PE20030444A1 (es) 2003-07-03
WO2003024440A1 (fr) 2003-03-27
JP2005504798A (ja) 2005-02-17
UY27443A1 (es) 2003-04-30
EP1429751A1 (fr) 2004-06-23
MXPA04002400A (es) 2004-05-31
JP4199114B2 (ja) 2008-12-17

Similar Documents

Publication Publication Date Title
CA2506109A1 (fr) Nouveaux derives de dihydroxymethylphenyle, procedes pour leur preparation, et utilisation desdits derives comme medicament
US20080132556A1 (en) 3-hydroxymethyl-4hydroxy-phenyl- derivatives for the treatment of respiratory diseases
CA2506082C (fr) Nouveaux medicaments destines au traitement de la maladie pulmonaire obstructive chronique
AU2003210172B2 (en) Novel fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals
CA2501055A1 (fr) Nouveaux betamimetiques a duree d'action prolongee, procedes de production et d'utilisation comme medicaments
US8044046B2 (en) Medicaments for the treatment of chronic obstructive pulmonary disease
AU2003206760B8 (en) Anticholinergic agents, method for producing the same and use thereof as medicaments
US6680345B2 (en) Salicylic acid salts of salmeterol
CA2471578C (fr) Esters d'acide xanthenecarboxylique de tropenol et de scopine servant d'antagonistes m3, procedes pour les produire et leur utilisation en tant que medicaments
CA2552871A1 (fr) Nouveaux beta-2-agonistes a action longue duree et leur utilisation comme medicaments
US6756508B2 (en) Cinnamic acid salts, processes for their preparation, and their use as medicaments
CA2477714C (fr) Nouveaux sels d'acide cinnamique, procedes de production et d'utilisation comme medicaments
CA2460440A1 (fr) Sels d'acide salicylique, procedes de production et d'utilisation desdits sels en tant que medicaments
CA2482637C (fr) Nouveaux esters d'heterocycles d'azote substitues par un hydroxy utilises comme antagonistes du recepteur m3 muscarinique, leur procede de production et leur utilisation comme medicaments
US7563806B2 (en) Substituted cycloalkyl derivatives, process for the manufacture thereof and use thereof as medicament
US7405232B2 (en) Long acting beta-2 agonists and their use as medicaments
US20030229227A1 (en) New difurylglycolic acid esters, processes for the preparation thereof as well as the use thereof as pharmaceutical compositions
CA2476746A1 (fr) Esters de tropenol d'acide difurylglycolique utilises comme anticholinergiques
DE10216125A1 (de) Salicylsäuresalze, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE10216124A1 (de) Neue Zimtsäuresalze, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
ZA200404366B (en) Novel fluorene carboxylic acid esters methods for the production thereof and use of the same as pharmaceuticals

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead